Correlation Between Qualigen Therapeutics and Quadro Acquisition
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Quadro Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Quadro Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Quadro Acquisition One, you can compare the effects of market volatilities on Qualigen Therapeutics and Quadro Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Quadro Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Quadro Acquisition.
Diversification Opportunities for Qualigen Therapeutics and Quadro Acquisition
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Qualigen and Quadro is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Quadro Acquisition One in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quadro Acquisition One and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Quadro Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quadro Acquisition One has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Quadro Acquisition go up and down completely randomly.
Pair Corralation between Qualigen Therapeutics and Quadro Acquisition
Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Quadro Acquisition. In addition to that, Qualigen Therapeutics is 44.96 times more volatile than Quadro Acquisition One. It trades about -0.04 of its total potential returns per unit of risk. Quadro Acquisition One is currently generating about 0.17 per unit of volatility. If you would invest 1,020 in Quadro Acquisition One on August 25, 2024 and sell it today you would earn a total of 31.00 from holding Quadro Acquisition One or generate 3.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 21.13% |
| Values | Daily Returns |
Qualigen Therapeutics vs. Quadro Acquisition One
Performance |
| Timeline |
| Qualigen Therapeutics |
| Quadro Acquisition One |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Qualigen Therapeutics and Quadro Acquisition Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Qualigen Therapeutics and Quadro Acquisition
The main advantage of trading using opposite Qualigen Therapeutics and Quadro Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Quadro Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quadro Acquisition will offset losses from the drop in Quadro Acquisition's long position.| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |